Blood pressure control and improved cardiovascular outcomes in the international verapamil SR-trandolapril study

Giuseppe Mancia; Franz Messerli; George Bakris; Qian Zhou; Annette Champion; Carl J. Pepine

doi:10.1161/HYPERTENSIONAHA.107.090290

Blood pressure control and improved cardiovascular outcomes in the international verapamil SR-trandolapril study

Giuseppe Mancia, Franz Messerli, George Bakris, Qian Zhou, Annette Champion, Carl J. Pepine

Fondazione Istituto Auxologico Italiano

Research output: Contribution to journal › Article › peer-review

Abstract

Uncontrolled blood pressure (BP) increases cardiovascular risk, independent of type of treatment. In this posthoc International Verapamil SR-Trandolapril Study analysis, we determined whether adverse outcomes are related to consistency of BP control, defined as the proportion of visits in which BP was in control. A total of 22 576 patients with hypertension and coronary artery disease were divided into 4 groups according to the proportion of visits in which BP was in control (

Original language	English
Pages (from-to)	299-305
Number of pages	7
Journal	Hypertension
Volume	50
Issue number	2
DOIs	https://doi.org/10.1161/HYPERTENSIONAHA.107.090290
Publication status	Published - Aug 2007

Keywords

Antihypertensive drugs
Antihypertensive treatment
Blood pressure control
Blood pressure measurement/monitoring
Clinical trials
Hypertension

ASJC Scopus subject areas

Internal Medicine

Access to Document

10.1161/HYPERTENSIONAHA.107.090290

Fingerprint Dive into the research topics of 'Blood pressure control and improved cardiovascular outcomes in the international verapamil SR-trandolapril study'. Together they form a unique fingerprint.

Cite this

@article{4cc4b0d554044cddbea4f1111b2b7efa,

title = "Blood pressure control and improved cardiovascular outcomes in the international verapamil SR-trandolapril study",

abstract = "Uncontrolled blood pressure (BP) increases cardiovascular risk, independent of type of treatment. In this posthoc International Verapamil SR-Trandolapril Study analysis, we determined whether adverse outcomes are related to consistency of BP control, defined as the proportion of visits in which BP was in control. A total of 22 576 patients with hypertension and coronary artery disease were divided into 4 groups according to the proportion of visits in which BP was in control (",

keywords = "Antihypertensive drugs, Antihypertensive treatment, Blood pressure control, Blood pressure measurement/monitoring, Clinical trials, Hypertension",

author = "Giuseppe Mancia and Franz Messerli and George Bakris and Qian Zhou and Annette Champion and Pepine, {Carl J.}",

year = "2007",

month = aug,

doi = "10.1161/HYPERTENSIONAHA.107.090290",

language = "English",

volume = "50",

pages = "299--305",

journal = "Hypertension",

issn = "0194-911X",

publisher = "Lippincott Williams and Wilkins",

number = "2",

}

TY - JOUR

T1 - Blood pressure control and improved cardiovascular outcomes in the international verapamil SR-trandolapril study

AU - Mancia, Giuseppe

AU - Messerli, Franz

AU - Bakris, George

AU - Zhou, Qian

AU - Champion, Annette

AU - Pepine, Carl J.

PY - 2007/8

Y1 - 2007/8

N2 - Uncontrolled blood pressure (BP) increases cardiovascular risk, independent of type of treatment. In this posthoc International Verapamil SR-Trandolapril Study analysis, we determined whether adverse outcomes are related to consistency of BP control, defined as the proportion of visits in which BP was in control. A total of 22 576 patients with hypertension and coronary artery disease were divided into 4 groups according to the proportion of visits in which BP was in control (

AB - Uncontrolled blood pressure (BP) increases cardiovascular risk, independent of type of treatment. In this posthoc International Verapamil SR-Trandolapril Study analysis, we determined whether adverse outcomes are related to consistency of BP control, defined as the proportion of visits in which BP was in control. A total of 22 576 patients with hypertension and coronary artery disease were divided into 4 groups according to the proportion of visits in which BP was in control (

KW - Antihypertensive drugs

KW - Antihypertensive treatment

KW - Blood pressure control

KW - Blood pressure measurement/monitoring

KW - Clinical trials

KW - Hypertension

UR - http://www.scopus.com/inward/record.url?scp=34547647776&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34547647776&partnerID=8YFLogxK

U2 - 10.1161/HYPERTENSIONAHA.107.090290

DO - 10.1161/HYPERTENSIONAHA.107.090290

M3 - Article

C2 - 17606861

AN - SCOPUS:34547647776

VL - 50

SP - 299

EP - 305

JO - Hypertension

JF - Hypertension

SN - 0194-911X

IS - 2

ER -